After
producing Brainstorm articles every month for
many years, Professessor Stephen Stahl, has
decided to stop this feature to enable him to
concentrate on other projects as described on
the website
of his institute
Depression-Webworld
can, therefore, no longer update this feature
although the Brainstorm articles currently on
the site will remain available (see
below).
April
2005
Brainstorms
available:
1.
Are
two antidepressant mechanisms better than
one?
2.
The
psychopharmacology of painful physical symptoms
in depression?
3.
Blue
genes and the monoamine hypothesis of
depression
4.
Blue
genes and the mechanism of action of
antidepressants
5.
The
7 habits of highly effective
psychopharmacologists
-
Part 1.
Overview
6.
The
7 habits of highly effective
psychopharmacologists
-
Part 2.
Begin
with the end in mind
7.
The
7 habits of highly effective
psychopharmacologists - Part
3.
Sharpen
the saw with selective choices of continuing
medical education programs
8.
The
7 habits of highly effective
psychopharmacologists - Part
4.
Developing
and implementing the vision
9.
The
psychopharmacology of energy and
fatigue
10.
Awakening
to the psychopharmacology of sleep and
arousal:
Novel
Neurotransmitters and Wake-promoting
Drugs
11.
Psychopharmacology
of wakefulness:
Pathways
and neurotransmitters
12.
Mergers
and acquisitions among
psychotropics:
Antidepressant
takeover of anxiety may now be
complete
13.
Does
evidence from clinical trials in
psychopharmacology apply in clinical
practice?
14.
Effects
of estrogen on the central nervous
system
15.
Natural
estrogen as an antidepressant for
women
16.
Why
settle for silver, when you can go for
gold?
Response
vs. recovery as the goal of antidepressant
therapy
17.
Antidepressants:
The
blue-chip psychotropic for the modern treatment
of anxiety disorders
18.
Antidepressants
and somatic symptoms:
Therapeutic
Actions Are Expanding Beyond Affective Spectrum
Disorders to Functional Somatic
Syndromes
19.
Molecular
neurobiology for practicing psychiatrists - Part
1.
Overview
of Gene Activation by
Neurotransmitters
20.
Molecular
neurobiology for practicing psychiatrists - Part
2.
How
Neurotransmitters Activate Second Messenger
Systems
21.
Molecular
neurobiology for practicing psychiatrists - Part
3.
Second
Messengers “Turn On” Genes by
Activating Protein Kinases and Transcription
Factors
22.
Molecular
neurobiology for practicing psychiatrists - Part
4.
Transferring
the Message of Chemical Neurotransmission From
Presynaptic Neurotransmitter to Postsynaptic
Gene Expression
23.
Molecular
neurobiology for practicing psychiatrists, Part
5.
How
a Leucine Zipper Can Turn On Genes:
Immediate-Early Genes Activate Late-Gene
Expression in the Brain
24.
Here
today and not gone
tomorrow:
The Curse of Chronic Pain and Other Central
Sensitization Syndromes
25.
The
psychopharmacology of sex, Part
1.
Neurotransmitters and the 3 Phases of the Human
Sexual Response
26.
The
psychopharmacology of sex, Part
2.
Effects of Drugs and Disease on the 3 Phases of
Human Sexual Response
27.
Deconstructing
psychiatric disorders, Part
1.
Genotypes, Symptom Phenotypes, and
Endophenotypes
28.
Deconstructing
psychiatric disorders, Part
2.
An Emerging, Neurobiologically Based Therapeutic
Strategy for the Modern
Psychopharmacologist
29.
Symptoms
and circuits, Part
1.
Major
Depressive Disorder
30.
Symptoms
and circuits, Part 2.
Anxiety
Disorders
31.
Neurotransmission
of cognition, Part 1.
Dopamine
Is a Hitchhiker in Frontal Cortex:
Norepinephrine Transporters Regulate
Dopamine
32.
Neurotransmission
of cognition, Part 2.
Selective
NRIs Are Smart Drugs: Exploiting Regionally
Selective Actions on Both Dopamine and
Norepinephrine to Enhance
Cognition
33.
Neurotransmission
of cognition, Part 3.
Mechanism
of Action of Selective NRIs: Both Dopamine and
Norepinephrine Increase in Prefrontal
Cortex
34.
Does
depression hurt?
35.
Fibromyalgia:
The
Enigma and the Stigma
36.
Gut
Feelings about Irritable Bowel
Syndrome
37.
Don’t
ask, don’t tell, but benzodiazepines are
still the leading treatments for anxiety
disorder
38.
Independent
actions on fear circuits may lead to therapeutic
synergy for anxiety when combining serotonergic
and GABAergic agents
39.
Anticonvulsants
as Anxiolytics, Part
1:
Tiagabine and Other Anticonvulsants With Actions
on GABA
40.
Anticonvulsants
as Anxiolytics, Part
2:
Pregabalin and Gabapentin as alpha-2-delta
Ligands at Voltage-Gated Calcium
Channels
41.
Drug
Combinations for Bipolar Spectrum
Disorders:
Evidence-Based Prescribing or Prescribing-Based
Evidence?
42.
Mental
Illness May Be Damaging to Your
Brain
43.
At
Long Last, Long-Lasting Psychiatric
Medications:
An
Overview of Controlled-Release
Technologies
44.
Anticonvulsants
as Mood Stabilizers and Adjuncts to
Antipsychotics:
Valproate,
Lamotrigine, Carbamazepine, and Oxcarbazepine
and Actions at Voltage-Gated Sodium
Channels
45.
Anticonvulsants
and the Relief of Chronic
Pain:
Pregabalin
and Gabapentin as
a2d
Ligands at Voltage-Gated Calcium
Channels
46.
Preemptive
Analgesia:
Is Pain Less Costly When You Pre-Pay For
It?
47.
Mirror,
Mirror on the Wall, Which Enantiomer Is Fairest
of Them All?
Brainstorm
articles: Copyright © The Journal of
Clinical Psychiatry
|
The
articles are in pdf format and require
a PDF Reader
- click here to download Acrobat PDF
Reader free
|
|
Updated
April 2005
